BioRestorative Therapies, Inc. ("BioRestorative,” "BRTX” or the "Company”) (NASDAQ: BRTX), a clinical-stage regenerative me ...

Glioblastoma (GBM) is the most aggressive and lethal form of brain cancer, with a median survival of only 15 months despite ...

Bioprinted epiblast-like structures mimic early human embryonic development, offering a scalable, ethical platform to study ...

Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, ...

Cells were immunostained for mesenchymal stem cell (MSC) markers, including CD90 (PE), CD271 (BV421), CD105 (BV650), CD73 (APC), and CD44 (PE-Cy7) (all from BD Bioscience), according to the ...

The mammary gland arises from multipotent stem cells (MaSCs), which are progressively ... Here, combined single-cell sequencing and ex vivo imaging reveal the earliest cell fate markers and ...

Engineering mesenchymal stromal cells with chimeric antigen receptors shows potential in enhancing their ability to target specific cells or markers and ... a bone marrow or stem cell transplant.

Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition ... We have previously identified both EpCAM and CD24 as CSC markers that, alongside the mesenchymal marker Vimentin, identify EMT ...

Mesenchymal stem cells are easy to isolate and culturally ... They should express specific cell surface markers, such as cluster of differentiation (CD) 73, D90, CD105, and lack the expression ...

Based on the distribution of Meflin/Islr-positive cells, we also considered it a specific candidate marker for mesenchymal stroma/stem cells. Meflin/Islr-positive CAFs have been shown to suppress ...

Furthermore, the percentage of cells expressing stem cell markers was lower in cells derived from cats than in canine cells. However, sex differences were observed only in osteogenic potential in the ...